drugset / Trial / NCT00493961

Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism

NCT00493961

Phase 1 Completed 27 enrolled Massachusetts General Hospital
Non-randomizedSingle-groupOpen-labelOther

Summary

Men with Idiopathic Hypogonadotropic Hypogonadism (IHH) lack a hormone called gonadotropin releasing hormone (GnRH). This hormone is important for starting puberty, maintaining testosterone levels, and fertility. The purpose of this study is to research the effects of treating IHH men with GnRH for 7 days.

Timeline

Start
1999-01
Primary completion
2009-11-17
Completion
2009-11-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonadorelin Protein / enzyme biologic 25 ng Intravenous

Indications